Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Frontiers in Pharmacology|December 12, 2022
NMI: a potential biomarker for tumor prognosis and immunotherapyTeng He, Yinbiao Qiao, Qi Yang, et al.Cancer Letters|April 3, 2024
JAML promotes the antitumor role of tumor-resident CD8+ T cells by facilitating their innate-like function in human lung cancerZhixing Hao, Zhongwei Xin, Yongyuan Chen, et al.Cell Reports|February 14, 2024
Inflammatory dendritic cells restrain CD11b+CD4+ CTLs via CD200R in human NSCLCMingjie Lin, Di Chen, Zheyu Shao, et al.Journal for Immunotherapy of Cancer|August 12, 2024
Epithelium/imcDC2 axis facilitates the resistance of neoadjuvant anti-PD-1 in human NSCLCYongyuan Chen, Zheyu Shao, Zhixing Hao, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 4, 2026
PD-1 Inhibits CD4+ TRM-Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLCZheyu Shao, Qinyuan Liu, Zhongwei Xin, et al.Med (New York, N.Y.)|February 14, 2026
COPD reshapes the tumor microenvironment of NSCLC and enhances anti-PD-1 therapy responseXiaoke Chen, Fang Ye, Sikun Liu, et al.Pageof 1